HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.

Abstract
A new, chemically distinct antagonist at dopamine 'D1-like' receptors, the thienoazepine LY 270411, ([+]-2(3-chloro-6-methyl-8-phenyl-5,6,7,8 -tetrahydro-4H-thieno[2,3d]azepin-2-yl)propan-2-ol) was compared with the isoquinoline BW 737C ([S]-6-chloro-1-[2,5-dimethoxy-4- propylbenzyl]-7-hydroxy-2-methyl-1,2,3,4-tetrahydroisoquinoline) and the benzazepine SCH 23390 ([R]-7-chloro-8-hydroxy-2,3,4,5-tetrahydro-3-methyl-1-phenyl-1 H-3-benzazepine) for effects on behavioural responses to the isochroman full efficacy dopamine 'D1-like' receptor agonist A 68930 ([1R,3S]-1-aminomethyl-5, 6-dihydroxy-3-phenylisochroman) vs. the dopamine 'D2-like' receptor agonist RU 24213 (N-n-propyl-N-phenylethyl-p-3-hydroxyphenylethylamine). Grooming responses to A 68930 were readily blocked by each of LY 270411, BW 737C and SCH 23390; however, the vacuous chewing response was blocked only by BW 737C. Sniffing and locomotor responses to RU 24213 were attenuated by BW 737C and SCH 23390 but not by LY 270411; furthermore, myoclonic jerking to RU 24213 was released by BW 737C and SCH 23390 but not by LY 270411. These findings indicate that grooming induced by dopamine 'D1-like' receptor agonism is blocked by all chemical classes of dopamine 'D1-like' receptor antagonist while vacuous chewing is blocked only by isoquinoline dopamine 'D1-like' receptor antagonism; this suggests that these behaviours may be mediated via functionally and pharmacologically distinct subtypes of dopamine 'D1-like' receptor. Furthermore, LY 270411 appears unique in its activity to readily block 'D1-like' receptor agonist-induced grooming without influencing behavioural responses to dopamine 'D2-like' receptor agonism; thus, the site mediating prototypical dopamine 'D1-like' receptor agonist-induced behaviours may be dissociable pharmacologically from dopamine 'D1-like' site(s) participating in functional interactions with dopamine 'D2-like' receptors.
AuthorsA M Deveney, J L Waddington
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 317 Issue 2-3 Pg. 175-81 (Dec 19 1996) ISSN: 0014-2999 [Print] Netherlands
PMID8997598 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Azepines
  • Chromans
  • Dopamine Agonists
  • Dopamine Antagonists
  • Isoquinolines
  • LY 270411
  • Phenethylamines
  • Receptors, Dopamine D1
  • Receptors, Dopamine D2
  • Tetrahydroisoquinolines
  • BW 737C89
  • Spiperone
  • N-n-propyl-N-phenylethyl-4(3-hydroxyphenyl)ethylamine hydrochloride
  • A 68930
Topics
  • Animals
  • Azepines (pharmacology)
  • Behavior, Animal (drug effects)
  • Chromans (pharmacology)
  • Dopamine Agonists (pharmacology)
  • Dopamine Antagonists (pharmacology)
  • Grooming (drug effects)
  • Isoquinolines (pharmacology)
  • Male
  • Motor Activity (drug effects)
  • Phenethylamines (pharmacology)
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Dopamine D1 (antagonists & inhibitors)
  • Receptors, Dopamine D2 (agonists)
  • Spiperone (metabolism)
  • Stereotyped Behavior (drug effects)
  • Tetrahydroisoquinolines

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: